{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:39:16Z","timestamp":1787017156505,"version":"build-2736575974"},"reference-count":48,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Czech Health Research Council of the Ministry of Health","award":["AZV No. NV18-06-00417"],"award-info":[{"award-number":["AZV No. NV18-06-00417"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,8,14]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Supraventricular arrhythmias contribute to haemodynamic compromise in septic shock. A retrospective study generated the hypothesis that propafenone could be more effective than amiodarone in achieving and maintaining sinus rhythm (SR). Certain echocardiographic parameters may predict a successful cardioversion and help in the decision on rhythm or rate control strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The trial includes septic shock patients with new-onset arrhythmia, but without severe impairment of the left ventricular ejection fraction. After baseline echocardiography, the patient is randomised to receive a bolus and maintenance dose of either amiodarone or propafenone. The primary outcome is the proportion of patients that have achieved rhythm control at 24\u2009hours after the start of the infusion. The secondary outcomes are the percentages of patients that needed rescue treatments (DC cardioversion or unblinding and crossover of the antiarrhythmics), the recurrence of arrhythmias, intensive care unit mortality, 28-day and 1-year mortality. In the posthoc analysis, we separately assess subgroups of patients with pulmonary hypertension and right ventricular dysfunction. In the exploratory part of the study, we assess whether the presence of a transmitral diastolic A wave and its higher velocity-time integral is predictive for the sustainability of mechanical SR and whether the indexed left atrial endsystolic volume is predictive of recurrent arrhythmia. Considering that the restoration of SR within 24\u2009hours occurred in 74% of the amiodarone-treated patients and in 89% of the patients treated with propafenone, we plan to include 200 patients to have an 80% chance to demonstrate the superiority of propafenone at p=0.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial is recruiting patients according to its second protocol version approved by the University Hospital Ethical Board on the 6 October 2017 (No. 1691\/16S-IV). The results will be disseminated through peer reviewed publications and conference presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03029169\">NCT03029169<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-031678","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T14:48:03Z","timestamp":1567522083000},"page":"e031678","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03029169","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1864-2143","authenticated-orcid":false,"given":"Martin","family":"Balik","sequence":"first","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Waldauf","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 3rd Medical Faculty, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Maly","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Matousek","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Brozek","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rulisek","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Porizka","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sachl","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Otahal","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Brestovansky","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Svobodova","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Flaksa","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Stach","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Pazout","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 3rd Medical Faculty, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantisek","family":"Duska","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 3rd Medical Faculty, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Smid","sequence":"additional","affiliation":[{"name":"2nd Department of Medicine, 1st Medical Faculty, Charles University and General Univeristy Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stritesky","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, 1st Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"2025120600225774000_9.9.e031678.1","first-page":"1","article-title":"Management of atrial fibrillation in critically ill patients","volume":"2014","author":"Arrigo","year":"2014","journal-title":"Crit Care Res Pract"},{"key":"2025120600225774000_9.9.e031678.2","doi-asserted-by":"crossref","unstructured":"Kuipers S , Klein Klouwenberg PMC , Cremer OL . Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care 2014;18.doi:10.1186\/s13054-014-0688-5","DOI":"10.1186\/s13054-014-0688-5"},{"key":"2025120600225774000_9.9.e031678.3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","article-title":"Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study","volume":"195","author":"Klein Klouwenberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2025120600225774000_9.9.e031678.4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcrc.2017.04.027","article-title":"Propafenone for supraventricular arrhythmias in septic shock\u2014Comparison to amiodarone and metoprolol","volume":"41","author":"Balik","year":"2017","journal-title":"J Crit Care"},{"key":"2025120600225774000_9.9.e031678.5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcrc.2018.01.024","article-title":"Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol. The authors reply","volume":"45","author":"Balik","year":"2018","journal-title":"J Crit Care"},{"key":"2025120600225774000_9.9.e031678.6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5603\/AIT.a2017.0061","article-title":"Management of arrhythmia in sepsis and septic shock","volume":"49","author":"Balik","year":"2017","journal-title":"Anaesthesiol Intensive Ther"},{"key":"2025120600225774000_9.9.e031678.7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2018.04.078","article-title":"New-onset atrial fibrillation in critically ill patients - Implications for rhythm rather than rate control therapy?","volume":"266","author":"Balik","year":"2018","journal-title":"Int J Cardiol"},{"key":"2025120600225774000_9.9.e031678.8","doi-asserted-by":"crossref","unstructured":"Liu WC , Lin WY , Lin CS , et al . Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation. Crit Care 2016;20.doi:10.1186\/s13054-016-1548-2","DOI":"10.1186\/s13054-016-1548-2"},{"key":"2025120600225774000_9.9.e031678.9","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1097\/CCM.0000000000001257","article-title":"Disappointing success of electrical cardioversion for new-onset atrial fibrillation in Cardiosurgical ICU patients","volume":"43","author":"Arrigo","year":"2015","journal-title":"Crit Care Med"},{"key":"2025120600225774000_9.9.e031678.10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1378\/chest.15-0959","article-title":"Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: a Propensity-Matched cohort study","volume":"149","author":"Walkey","year":"2016","journal-title":"Chest"},{"key":"2025120600225774000_9.9.e031678.11","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31828a678d"},{"key":"2025120600225774000_9.9.e031678.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278477"},{"key":"2025120600225774000_9.9.e031678.13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00508-012-0209-y","article-title":"Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock","volume":"124","author":"Balik","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"2025120600225774000_9.9.e031678.14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00508-013-0487-z","article-title":"Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. reply to a letter to the authors","volume":"126","author":"Balik","year":"2014","journal-title":"Wien Klin Wochenschr"},{"key":"2025120600225774000_9.9.e031678.15","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s00134-016-4407-3","article-title":"Beta-Blockers in septic shock to optimize hemodynamics? no","volume":"42","author":"McLean","year":"2016","journal-title":"Intensive Care Med"},{"key":"2025120600225774000_9.9.e031678.16","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut263"},{"key":"2025120600225774000_9.9.e031678.17","doi-asserted-by":"crossref","unstructured":"Sleeswijk ME , Van Noord T , Tulleken JE , Ligtenberg JJ , et al . Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients: a clinical framework. Crit Care 2007;11.doi:10.1186\/cc6136","DOI":"10.1186\/cc6136"},{"key":"2025120600225774000_9.9.e031678.18","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1097\/CCM.0000000000001257","article-title":"Disappointing success of electrical cardioversion for new-onset atrial fibrillation in Cardiosurgical ICU patients","volume":"43","author":"Arrigo","year":"2015","journal-title":"Crit Care Med"},{"key":"2025120600225774000_9.9.e031678.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.11.005"},{"key":"2025120600225774000_9.9.e031678.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197352","article-title":"Which antiarrhythmic drug to choose after electrical cardioversion: a study on non-valvular atrial fibrillation patients","volume":"13","author":"Gwag","year":"2018","journal-title":"PLoS One"},{"key":"2025120600225774000_9.9.e031678.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210"},{"key":"2025120600225774000_9.9.e031678.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-008-1017-2"},{"key":"2025120600225774000_9.9.e031678.23","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000151048.72393.44"},{"key":"2025120600225774000_9.9.e031678.24","first-page":"Ud01","article-title":"Acute Respiratory Distress Syndrome Complicated by Amiodarone Induced Pulmonary Fibrosis: Don't Let Your Guard Down","volume":"11","author":"Singh","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"2025120600225774000_9.9.e031678.25","doi-asserted-by":"publisher","DOI":"10.1007\/s001340000668"},{"key":"2025120600225774000_9.9.e031678.26","doi-asserted-by":"publisher","DOI":"10.2165\/11532320-000000000-00000"},{"key":"2025120600225774000_9.9.e031678.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103213241201"},{"key":"2025120600225774000_9.9.e031678.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02705-5"},{"key":"2025120600225774000_9.9.e031678.29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5603\/CJ.2013.0035","article-title":"Arrhythmogenic effect of flecainide toxicity","volume":"20","author":"Courand","year":"2013","journal-title":"Cardiol J"},{"key":"2025120600225774000_9.9.e031678.30","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euq382"},{"key":"2025120600225774000_9.9.e031678.31","unstructured":"Varon J , Marik PE Irwin RS , Rippe JM , eds. Irwin and Rippe's intensive care medicine. 6th ed. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins, 2008: 1855\u201369."},{"key":"2025120600225774000_9.9.e031678.32","unstructured":"Ganetsky MBE . Antiarythmic agents. In: Irwin RS RJ , ed. Intensive care medicine. 6th ed. Philadelphia: Wolters Kluwer\/Lippincott, Williams&Wilkins, 2008: 1486\u201398."},{"key":"2025120600225774000_9.9.e031678.33","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv195"},{"key":"2025120600225774000_9.9.e031678.34","doi-asserted-by":"crossref","unstructured":"Lafuente-Lafuente C , Valembois L , Bergmann J-F , et al . Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2015;151.doi:10.1002\/14651858.CD005049.pub4","DOI":"10.1002\/14651858.CD005049.pub4"},{"key":"2025120600225774000_9.9.e031678.35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11739-016-1497-4","article-title":"Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class Ic antiarrhythmic drugs","volume":"12","author":"Bonora","year":"2017","journal-title":"Intern Emerg Med"},{"key":"2025120600225774000_9.9.e031678.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021375"},{"key":"2025120600225774000_9.9.e031678.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021328"},{"key":"2025120600225774000_9.9.e031678.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404380"},{"key":"2025120600225774000_9.9.e031678.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602002"},{"key":"2025120600225774000_9.9.e031678.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.07.116"},{"key":"2025120600225774000_9.9.e031678.41","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeu193"},{"key":"2025120600225774000_9.9.e031678.42","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jep007"},{"key":"2025120600225774000_9.9.e031678.43","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jeq176"},{"key":"2025120600225774000_9.9.e031678.44","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050372"},{"key":"2025120600225774000_9.9.e031678.45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"2025120600225774000_9.9.e031678.46","doi-asserted-by":"crossref","unstructured":"Repess\u00e9 X , Charron C , Vieillard-Baron A . Evaluation of left ventricular systolic function revisited in septic shock. Crit Care 2013;17.doi:10.1186\/cc12755","DOI":"10.1186\/cc12755"},{"key":"2025120600225774000_9.9.e031678.47","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B"},{"key":"2025120600225774000_9.9.e031678.48","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/CCM.0000000000002512","article-title":"The impact of the Sepsis-3 septic shock definition on previously defined septic shock patients","volume":"45","author":"Sterling","year":"2017","journal-title":"Crit Care Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-031678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:23:05Z","timestamp":1765009385000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-031678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,3]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bmjopen-2019-031678"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-031678","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}